We are driven to make access to cell and gene therapies available, regardless of who the patient is or where they live. Read our second whitepaper on equitable access. https://lnkd.in/eyafeZni #UnipharAccess #MarketAccess #GlobalAccess #CellAndGene #Uniphar
Uniphar | Access’ Post
More Relevant Posts
-
We are driven to make access to cell and gene therapies available, regardless of who the patient is or where they live. Read our second whitepaper on equitable access. https://lnkd.in/eyafeZni #UnipharAccess #MarketAccess #GlobalAccess #CellAndGene #Uniphar
To view or add a comment, sign in
-
-
Plasmids, used to deliver gene therapies, must be free of contaminating proteins that may cause adverse side effects. UV-Vis spectrophotometry is a fast and simple technique that can be easily implemented at several points in the plasmid manufacturing workflow to help ensure consistency and to maintain safety and efficacy. Learn how. https://lnkd.in/gfisHJa6 #TFSCAD
To view or add a comment, sign in
-
-
Developments in #GeneTherapies are changing the landscape of healthcare, it’s important for employers to understand their impact and opportunities these advancements may bring. Check out the latest installment in our 2024 Future Forecast video series to learn more about gene therapies: https://bit.ly/3OYHo2R #FutureForecast #SunLifeUS
To view or add a comment, sign in
-
-
With the approvals of many new cell and gene therapies, we're moving into a new era of hope for patients. But not without challenges. We believe partnership within the broader CAGT ecosystem will create advantages in the years ahead. In this report, our experts share insights that can help bring these complex treatments to market faster and more efficiently. Preview it here or click to download the full report: https://lnkd.in/g2GcidPy #cellandgenetherapy #cellandgene
To view or add a comment, sign in
-
To produce gene therapies safely, cost-effectively and with urgency to meet growing global health needs, collaboration among professionals is essential. We know that sharing knowledge of what works, and what doesn’t, can speed the process of getting life-saving treatments to patients. Dr. Arvind Srivastava examines specific challenges related to #gene stability, and new solutions for improvement, to showcase the value of partnerships. https://lnkd.in/eK7NyXhU #genetherapies #viralvectors
To view or add a comment, sign in
-
-
A creative mind, seeking my next adventure! | Gene therapy | Preclinical testing | Protein engineering and production | Project Leadership and Management
Brazil is following in India's (https://lnkd.in/dCXCbX-9 ) footsteps in an endeavor to enhance accessibility to advanced cell and gene therapies by lowering their costs. https://lnkd.in/djQAd_4H
To view or add a comment, sign in
-
-
What’s next for the cell and gene therapy (CGT) industry? The findings from our upcoming 2023 CGT Industry Survey tell an optimistic story, while identifying key areas of concern to focus on in the coming years. Check out the highlights below and be on the lookout for the full report in a few weeks. #CellTherapy #GeneTherapy #PersonalizedMedicine Jennifer Rabin Jessica Faust Chiara Cerati Omkar Kawalekar Hussain Mooraj Amit Agarwal
To view or add a comment, sign in
-
-
Rethinking ecosystems to enable access https://lnkd.in/etktvGiz Cell and gene therapy in the Asia-Pacific region. This update includes insights for overcoming the challenges of affordability and navigating healthcare systems in the Asia-Pacific region, especially in resource-constrained markets. It also explains why public-private partnerships and policy-shaping are key in building a future with optimal access to transformative cell and gene therapies in the region. https://lnkd.in/etktvGiz #HEOR #MarketAccess #WeAreAvalereHealth
To view or add a comment, sign in
-
-
#cellandgenetherapy products need to prepare for the new EU #HTA Regulation now to be ready for 2025 submissions. This white paper will help you better understand what you need to do to prepare.
How will new health technology assessment (#HTA) regulations coming to the European Union (EU) in 2025 impact your cell and gene therapy (#CGT) submission? Read on for answers. » https://bit.ly/3O4OkvM
To view or add a comment, sign in